Versartis Reports Third Quarter 2016 Financial Results
Nov 03, 2016 20:05 pm UTC| Business
MENLO PARK, Calif., Nov. 03, 2016 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone...
Impinj Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:03 pm UTC| Business
SEATTLE, Nov. 03, 2016 -- Impinj, Inc.(NASDAQ:PI), a leading provider and pioneer of RAIN RFID solutions for identifying, locating and authenticating everyday items, today announced its financial results for the third...
Applied Optoelectronics Reports Third Quarter 2016 Results
Nov 03, 2016 20:03 pm UTC| Business
SUGAR LAND, Texas, Nov. 03, 2016 -- Applied Optoelectronics, Inc. (NASDAQ:AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband, and fiber-to-the-home markets,...
Entellus Medical Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:03 pm UTC| Business
PLYMOUTH, Minn., Nov. 03, 2016 -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering superior patient and physician experiences through products designed for the minimally invasive...
Qorvo® Announces $500 Million Share Repurchase Program
Nov 03, 2016 20:02 pm UTC| Business
GREENSBORO, N.C., Nov. 03, 2016 -- Qorvo® (Nasdaq:QRVO), a leading provider of innovative RF solutions that connect the world, today announced that its Board of Directors has authorized the repurchase of up to $500...
SAExploration Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:02 pm UTC| Business
HOUSTON, Nov. 03, 2016 -- SAExploration Holdings, Inc. (NASDAQ:SAEX) (“SAE” or the “Company”) today announced its consolidated financial results for the third quarter (“Q3”) and nine months ended September 30, 2016. ...
Xenon Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Nov 03, 2016 20:02 pm UTC| Business
BURNABY, British Columbia, Nov. 03, 2016 -- Xenon Pharmaceuticals Inc.(Nasdaq:XENE), a clinical-stage biopharmaceutical company, today reported its financial results for the quarter ended September 30, 2016 and provided...